vs
Side-by-side financial comparison of DaVita (DVA) and PAN AMERICAN SILVER CORP (PAAS). Click either name above to swap in a different company.
DaVita is the larger business by last-quarter revenue ($3.6B vs $2.8B, roughly 1.3× PAN AMERICAN SILVER CORP).
DaVita Inc. is an American company that provides kidney dialysis services through a network of 2,675 outpatient centers in the United States, serving 200,800 patients, and 367 outpatient centers in 11 other countries serving 49,400 patients. The company primarily treats end-stage renal disease (ESRD), which requires patients to undergo kidney dialysis, often 3 times per week for the rest of their lives unless they receive a kidney transplant via organ donation.
Pan American Silver Corporation is a mining company based in Canada with operations in Latin America. The company has mines and other projects in Mexico, Peru, Bolivia, and Argentina.
DVA vs PAAS — Head-to-Head
Income Statement — Q1 FY2026 vs Q3 FY2022
| Metric | | |
|---|---|---|
| Revenue | $3.6B | $2.8B |
| Net Profit | $234.2M | — |
| Gross Margin | — | 27.0% |
| Operating Margin | 15.5% | — |
| Net Margin | 6.5% | — |
| Revenue YoY | 12.3% | — |
| Net Profit YoY | 43.8% | — |
| EPS (diluted) | $3.22 | $-1.05 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $3.6B | — | ||
| Q4 25 | $3.6B | — | ||
| Q3 25 | $3.4B | — | ||
| Q2 25 | $3.4B | — | ||
| Q1 25 | $3.2B | — | ||
| Q4 24 | $3.3B | — | ||
| Q3 24 | $3.3B | — | ||
| Q2 24 | $3.2B | — |
| Q1 26 | $234.2M | — | ||
| Q4 25 | $234.2M | — | ||
| Q3 25 | $150.3M | — | ||
| Q2 25 | $199.3M | — | ||
| Q1 25 | $162.9M | — | ||
| Q4 24 | $259.3M | — | ||
| Q3 24 | $214.7M | — | ||
| Q2 24 | $222.7M | — |
| Q1 26 | 15.5% | — | ||
| Q4 25 | 15.5% | — | ||
| Q3 25 | 14.8% | — | ||
| Q2 25 | 15.9% | — | ||
| Q1 25 | 13.6% | — | ||
| Q4 24 | 17.2% | — | ||
| Q3 24 | 16.4% | — | ||
| Q2 24 | 15.9% | — |
| Q1 26 | 6.5% | — | ||
| Q4 25 | 6.5% | — | ||
| Q3 25 | 4.4% | — | ||
| Q2 25 | 5.9% | — | ||
| Q1 25 | 5.1% | — | ||
| Q4 24 | 7.9% | — | ||
| Q3 24 | 6.6% | — | ||
| Q2 24 | 7.0% | — |
| Q1 26 | $3.22 | — | ||
| Q4 25 | $3.22 | — | ||
| Q3 25 | $2.04 | — | ||
| Q2 25 | $2.58 | — | ||
| Q1 25 | $2.00 | — | ||
| Q4 24 | $3.08 | — | ||
| Q3 24 | $2.50 | — | ||
| Q2 24 | $2.50 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $700.7M | — |
| Total DebtLower is stronger | $10.2B | — |
| Stockholders' EquityBook value | $-651.1M | — |
| Total Assets | $17.5B | — |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $700.7M | — | ||
| Q4 25 | $700.7M | — | ||
| Q3 25 | $736.5M | — | ||
| Q2 25 | $739.4M | — | ||
| Q1 25 | $511.9M | — | ||
| Q4 24 | $846.0M | — | ||
| Q3 24 | $1.1B | — | ||
| Q2 24 | $437.2M | — |
| Q1 26 | $10.2B | — | ||
| Q4 25 | $10.2B | — | ||
| Q3 25 | $10.2B | — | ||
| Q2 25 | $10.1B | — | ||
| Q1 25 | $9.6B | — | ||
| Q4 24 | $9.2B | — | ||
| Q3 24 | $9.3B | — | ||
| Q2 24 | $8.5B | — |
| Q1 26 | $-651.1M | — | ||
| Q4 25 | $-651.1M | — | ||
| Q3 25 | $-571.9M | — | ||
| Q2 25 | $-369.6M | — | ||
| Q1 25 | $-267.1M | — | ||
| Q4 24 | $121.1M | — | ||
| Q3 24 | $386.7M | — | ||
| Q2 24 | $632.9M | — |
| Q1 26 | $17.5B | — | ||
| Q4 25 | $17.5B | — | ||
| Q3 25 | $17.6B | — | ||
| Q2 25 | $17.5B | — | ||
| Q1 25 | $17.1B | — | ||
| Q4 24 | $17.3B | — | ||
| Q3 24 | $17.5B | — | ||
| Q2 24 | $17.0B | — |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 75.76× | — | ||
| Q3 24 | 23.95× | — | ||
| Q2 24 | 13.35× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
